Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kong, Fang Fang ^a,b   Ying, Hongmei ^a,b   Du, Cheng Run ^a,b   Huang, Shuang ^a,b   Zhou, Jun Jun ^a,b   Hu, Chao Su ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

AGED; ALOPECIA; AMNESIA; ANEMIA; ARTICLE; BLOOD TOXICITY; BRAIN NECROSIS; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; DIARRHEA; DISTANT METASTASIS; FAILURE FREE SURVIVAL; FEMALE; HEADACHE; HEARING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DERMATITIS; RADIATION DOSE; RETROSPECTIVE STUDY; SCORING SYSTEM; TEMPORAL LOBE; THROMBOCYTOPENIA; TREATMENT FAILURE; TUMOR VOLUME; VERY ELDERLY; XEROSTOMIA; ADOLESCENT; ADULT; KAPLAN MEIER METHOD; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CISPLATIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84897420700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091362     Document Type: Article

References (20)

1. Lu H, Yao M (2008) The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev 34: 27-36. (Pubitemid 351187501)
2. Teo P, Yu P, Lee WY, Leung SF, Kwan WH, et al. (1996) Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36: 291-304. (Pubitemid 26359452)
3. Sanguineti G, Geara FB, Garden AS, Tucker SL, Ang KK, et al. (1997) Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 37: 985-996. (Pubitemid 27230021)
4. Lee AW, Au JS, Teo PM, Leung TW, Chua DT, et al. (2004) Staging of nasopharyngeal carcinoma: suggestions for improving the current UICC/AJCC Staging System. Clin Oncol (R Coll Radiol) 16: 269-276. (Pubitemid 38696968)
5. Yi JL, Gao L, Huang XD, Li SY, Luo JW, et al. (2006) Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution. Int J Radiat Oncol Biol Phys 65: 161-168.
6. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ (2000) Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48: 329-337.
7. Cheng JC, Chao KS, Low D (2001) Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer 96: 126-131. (Pubitemid 32291433)
8. Hunt MA, Zelefsky MJ, Wolden S, Chui CS, LoSasso T, et al. (2001) Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 49: 623-632. (Pubitemid 32112190)
9. Kam MK, Chau RM, Suen J, Choi PH, Teo PM (2003) Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56: 145-157. (Pubitemid 36403686)
10. Kwong DL, Pow EH, Sham JS, McMillan AS, Leung LH, et al. (2004) Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 101: 1584-1593. (Pubitemid 39318905)
11. Su SF, Han F, Zhao C, Chen CY, Xiao WW, et al. (2012) Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys 82: 327-333.
12. Ma BB, Kam MK, Leung SF, Hui EP, King AD, et al. (2012) A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 23: 1287-1292.
13. Xiao WW, Huang SM, Han F, Wu SX, Lu LX, et al. (2011) Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 117: 1874-1883.
14. Cao CN, Luo JW, Gao L, Yi JL, Huang XD, et al. (2013) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma. Oral Oncol 49: 175-181.
15. Hui EP, Ma BB, Leung SF, King AD, Mo F, et al. (2009) Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 27: 242-249.
16. Xu T, Hu C, Zhu G, He X, Wu Y, et al. (2012) Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Med Oncol 29: 272-278.
17. Du C, Ying H, Zhou J, Hu C, Zhang Y (2013) Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Int J Clin Oncol 18: 464-471.
18. Ng WT, Lee MC, Hung WM, Choi CW, Lee KC, et al. (2011) Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 79: 420-428.
19. Anne W, Stephen C, Stewart Y, Ho M, John H (1998) Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40: 35-42.
20. Lee AW, Kwong DL, Leung SF, Tung SY, Sze WM, et al. (2002) Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 53: 75-85. (Pubitemid 34465809)